A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response

By Michael B. Reed, P. Domènech, C. Manca, Hua Su, A. Barczak, Barry N. Kreiswirth, G. Kaplan, C. Barry. Nature, 2004

743 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/0e2ad0cdaebac213c6306c9ee512956d08b0c343

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. A. O’Garra
2. R. Wilkinson
3. M. Berry
4. Finlay W Mcnab
5. Paul S. Redford
6. C. Bloom

In Infectious Diseases

1. A. O’Garra
2. R. Wilkinson
3. M. Berry
4. Finlay W Mcnab
5. Paul S. Redford
6. C. Bloom

Citations in the corpus

• The immune response in tuberculosis. (2013, background): “tuberculosis genotypes (22–26, 99, 332) may be associated with an increased risk of developing active TB and with the level of disease severity (24, 25, 98, 317, 332, 333).”
• Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates (2008, methodology): “7H11 agar and frozen as described previously (34).”